CAMBRIDGE, Mass.--(BUSINESS WIRE)--Galenea Corp., a leader in the rapidly emerging field of synaptic transmission, is pleased to announce the appointment of Timothy Ryan, PhD. to its Scientific Advisory Board. Dr. Ryan is a leading expert on mechanisms of synaptic transmission and in developing new techniques to study this process. “We are thrilled to welcome Dr. Ryan to our Scientific Advisory Board,” commented Dr. David Gerber, Vice President of CNS Research at Galenea. “He has tremendous knowledge of synaptic transmission and has been on the forefront of developing new experimental techniques. Dr. Ryan has already made major contributions to the development of our MANTRA™ system, and as a member of our SAB he will be essential to pushing this unique system for high throughput synaptic functional screening to the next level.”
